Literature DB >> 7888849

Audit of secondary prophylaxis after myocardial infarction.

D L Whitford1, A J Southern.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7888849      PMCID: PMC2541787          DOI: 10.1136/bmj.309.6964.1268

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  2 in total

1.  Beta blockade during and after myocardial infarction: an overview of the randomized trials.

Authors:  S Yusuf; R Peto; J Lewis; R Collins; P Sleight
Journal:  Prog Cardiovasc Dis       Date:  1985 Mar-Apr       Impact factor: 8.194

2.  Use of secondary prophylaxis against myocardial infarction in the north of England.

Authors:  M Eccles; C Bradshaw
Journal:  BMJ       Date:  1991-01-12
  2 in total
  12 in total

1.  Improving aspirin prophylaxis after myocardial infarction in primary care: collaboration in multipractice audit between primary care audit group and health authority.

Authors:  K Khunti; R Sorrie; S Jennings; A Farooqi
Journal:  BMJ       Date:  1999-07-31

Review 2.  Development and evaluation of complex interventions in health services research: case study of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group.

Authors:  F Bradley; R Wiles; A L Kinmonth; D Mant; M Gantley
Journal:  BMJ       Date:  1999-03-13

3.  Cardiac rehabilitation in the United Kingdom: guidelines and audit standards. National Institute for Nursing, the British Cardiac Society and the Royal College of Physicians of London.

Authors:  D R Thompson; G S Bowman; A L Kitson; D P de Bono; A Hopkins
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

Review 4.  Under-utilisation of beta-blockers after acute myocardial infarction. Pharmacoeconomic implications.

Authors:  W D Bradford; J Chen; H M Krumholz
Journal:  Pharmacoeconomics       Date:  1999-03       Impact factor: 4.981

5.  Aspirin and acute myocardial infarction: clarifying the message.

Authors:  J Deeks; I Watt; N Freemantle
Journal:  Br J Gen Pract       Date:  1995-08       Impact factor: 5.386

6.  Secondary prophylaxis after myocardial infarction.

Authors:  D G Julian
Journal:  BMJ       Date:  1995-01-07

7.  Aspirin use in middle-aged men with cardiovascular disease: are opportunities being missed?

Authors:  A K McCallum; P H Whincup; R W Morris; A Thomson; M Walker; S Ebrahim
Journal:  Br J Gen Pract       Date:  1997-07       Impact factor: 5.386

Review 8.  Is aspirin underused in myocardial infarction?

Authors:  J M Arnau; A Agustí
Journal:  Pharmacoeconomics       Date:  1997-11       Impact factor: 4.981

9.  Economic assessment of the secondary prevention of ischaemic events with lysine acetylsalicylate.

Authors:  J P Marissal; B Selke; T Lebrun
Journal:  Pharmacoeconomics       Date:  2000-08       Impact factor: 4.981

10.  Missing, mediocre, or merely obsolete? An evaluation of UK data sources for coronary heart disease.

Authors:  B Unal; J A Critchley; S Capewell
Journal:  J Epidemiol Community Health       Date:  2003-07       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.